Canakinumab
Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody that inhibits human and chorioallantoic monkey IL-1β with IC50 values of 43.6 and 40.8 pM, respectively. It exhibits anti-inflammatory activity by neutralizing IL-1β signaling, and it has been used for the treatment of gout and coronary artery disease.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
CAS Number
914613-48-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1071268-01 0.02 mg (E-Coli)
Recombinant Thermococcus sibiricus UPF0212 protein TSIB_1358 (TSIB_1358)
Ask
View Details MBS1071268-02 0.1 mg (E-Coli)
Recombinant Thermococcus sibiricus UPF0212 protein TSIB_1358 (TSIB_1358)
Ask
View Details 
MBS1071268-03 0.02 mg (Yeast)
Recombinant Thermococcus sibiricus UPF0212 protein TSIB_1358 (TSIB_1358)
Ask
View Details MBS1071268-04 0.1 mg (Yeast)
Recombinant Thermococcus sibiricus UPF0212 protein TSIB_1358 (TSIB_1358)
Ask
View Details